Elekta included in FTSE4Good Index Series

STOCKHOLM--()--Regulatory News:

Elekta has been added to the FTSE4Good Index Series (http://www.ftse.com/products/indices/FTSE4Good). This is a set of indices defined by the FTSE that measures the performance of companies demonstrating strong environmental, social and governance (ESG) practices.

Launched in 2001, the index is designed for use in the creation of index tracking funds, derivatives and as a performance benchmark. This is the first year that Elekta has been included.

Brittmarie Djurle, Global Vice President, CSR & Risk Management, at Elekta, says: “We are proud to receive recognition for our ESG efforts. Being included in the FTSE4Good Index Series is an acknowledgement of the progress we are making in, for example, implementing Code of Conduct and Anti-Corruption guidelines, enforcing labor standards as well as becoming more environmentally sustainable.

Index governance is overseen by the independent FTSE4Good Advisory Committee, made up of leading global responsible investment market practitioners and experts in the principles and criteria use for determining the social responsibility of corporate entities.

# # #

For further information, please contact:

Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time

Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time

The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on October 8, 2014.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.

This information was brought to you by Cision http://news.cision.com

Contacts

Elekta AB
Gert van Santen, +31 653 561 242
Group Vice President Corporate Communications
gert.vansanten@elekta.com
or
Johan Andersson, +46 702 100 451
Director, Investor Relations
johan.andersson@elekta.com

Contacts

Elekta AB
Gert van Santen, +31 653 561 242
Group Vice President Corporate Communications
gert.vansanten@elekta.com
or
Johan Andersson, +46 702 100 451
Director, Investor Relations
johan.andersson@elekta.com